nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—SLC22A11—Methotrexate—testicular cancer	0.172	0.429	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—testicular cancer	0.1	0.249	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—testicular cancer	0.0698	0.174	CbGbCtD
Ceftriaxone—ALB—Methotrexate—testicular cancer	0.0595	0.148	CbGbCtD
Ceftriaxone—Chills—Etoposide—testicular cancer	0.000991	0.00166	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Methotrexate—testicular cancer	0.000988	0.00165	CcSEcCtD
Ceftriaxone—Infection—Ifosfamide—testicular cancer	0.000987	0.00165	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Cisplatin—testicular cancer	0.000973	0.00163	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Ifosfamide—testicular cancer	0.000972	0.00163	CcSEcCtD
Ceftriaxone—Anaemia—Cisplatin—testicular cancer	0.00097	0.00162	CcSEcCtD
Ceftriaxone—Phlebitis—Doxorubicin—testicular cancer	0.000961	0.00161	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Ifosfamide—testicular cancer	0.00096	0.00161	CcSEcCtD
Ceftriaxone—Feeling abnormal—Bleomycin—testicular cancer	0.000958	0.0016	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Doxorubicin—testicular cancer	0.000956	0.0016	CcSEcCtD
Ceftriaxone—Vomiting—Chlorambucil—testicular cancer	0.000955	0.0016	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Epirubicin—testicular cancer	0.000948	0.00159	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000947	0.00158	CcSEcCtD
Ceftriaxone—Malaise—Cisplatin—testicular cancer	0.000946	0.00158	CcSEcCtD
Ceftriaxone—Diarrhoea—Vinblastine—testicular cancer	0.000941	0.00157	CcSEcCtD
Ceftriaxone—Dysgeusia—Etoposide—testicular cancer	0.000941	0.00157	CcSEcCtD
Ceftriaxone—Renal impairment—Epirubicin—testicular cancer	0.00094	0.00157	CcSEcCtD
Ceftriaxone—Leukopenia—Cisplatin—testicular cancer	0.000939	0.00157	CcSEcCtD
Ceftriaxone—Pain—Dactinomycin—testicular cancer	0.000927	0.00155	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Epirubicin—testicular cancer	0.000924	0.00155	CcSEcCtD
Ceftriaxone—Urticaria—Bleomycin—testicular cancer	0.000923	0.00154	CcSEcCtD
Ceftriaxone—Body temperature increased—Bleomycin—testicular cancer	0.000919	0.00154	CcSEcCtD
Ceftriaxone—Dizziness—Vinblastine—testicular cancer	0.00091	0.00152	CcSEcCtD
Ceftriaxone—Convulsion—Cisplatin—testicular cancer	0.000909	0.00152	CcSEcCtD
Ceftriaxone—Ataxia—Methotrexate—testicular cancer	0.000899	0.0015	CcSEcCtD
Ceftriaxone—Feeling abnormal—Dactinomycin—testicular cancer	0.000893	0.00149	CcSEcCtD
Ceftriaxone—Nausea—Chlorambucil—testicular cancer	0.000892	0.00149	CcSEcCtD
Ceftriaxone—Paraesthesia—Ifosfamide—testicular cancer	0.000892	0.00149	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Etoposide—testicular cancer	0.000892	0.00149	CcSEcCtD
Ceftriaxone—Anaemia—Etoposide—testicular cancer	0.000888	0.00149	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000886	0.00148	CcSEcCtD
Ceftriaxone—Discomfort—Cisplatin—testicular cancer	0.000882	0.00148	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.000877	0.00147	CcSEcCtD
Ceftriaxone—Vomiting—Vinblastine—testicular cancer	0.000875	0.00146	CcSEcCtD
Ceftriaxone—Renal impairment—Doxorubicin—testicular cancer	0.00087	0.00145	CcSEcCtD
Ceftriaxone—Malaise—Etoposide—testicular cancer	0.000867	0.00145	CcSEcCtD
Ceftriaxone—Headache—Vinblastine—testicular cancer	0.000862	0.00144	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000861	0.00144	CcSEcCtD
Ceftriaxone—Leukopenia—Etoposide—testicular cancer	0.00086	0.00144	CcSEcCtD
Ceftriaxone—Abdominal pain—Dactinomycin—testicular cancer	0.000857	0.00143	CcSEcCtD
Ceftriaxone—Body temperature increased—Dactinomycin—testicular cancer	0.000857	0.00143	CcSEcCtD
Ceftriaxone—Oedema—Cisplatin—testicular cancer	0.000856	0.00143	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Cisplatin—testicular cancer	0.000856	0.00143	CcSEcCtD
Ceftriaxone—Hypersensitivity—Bleomycin—testicular cancer	0.000856	0.00143	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000855	0.00143	CcSEcCtD
Ceftriaxone—Infection—Cisplatin—testicular cancer	0.000851	0.00142	CcSEcCtD
Ceftriaxone—Pain—Ifosfamide—testicular cancer	0.000849	0.00142	CcSEcCtD
Ceftriaxone—Ataxia—Epirubicin—testicular cancer	0.000841	0.00141	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Cisplatin—testicular cancer	0.000838	0.0014	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Epirubicin—testicular cancer	0.000838	0.0014	CcSEcCtD
Ceftriaxone—Convulsion—Etoposide—testicular cancer	0.000833	0.00139	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Cisplatin—testicular cancer	0.000828	0.00138	CcSEcCtD
Ceftriaxone—Pruritus—Bleomycin—testicular cancer	0.000822	0.00138	CcSEcCtD
Ceftriaxone—Feeling abnormal—Ifosfamide—testicular cancer	0.000818	0.00137	CcSEcCtD
Ceftriaxone—Eosinophilia—Methotrexate—testicular cancer	0.000818	0.00137	CcSEcCtD
Ceftriaxone—Nausea—Vinblastine—testicular cancer	0.000817	0.00137	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Epirubicin—testicular cancer	0.000817	0.00137	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000812	0.00136	CcSEcCtD
Ceftriaxone—Pancreatitis—Methotrexate—testicular cancer	0.00081	0.00135	CcSEcCtD
Ceftriaxone—Discomfort—Etoposide—testicular cancer	0.000808	0.00135	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000806	0.00135	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000806	0.00135	CcSEcCtD
Ceftriaxone—Hypersensitivity—Dactinomycin—testicular cancer	0.000798	0.00134	CcSEcCtD
Ceftriaxone—Urticaria—Ifosfamide—testicular cancer	0.000789	0.00132	CcSEcCtD
Ceftriaxone—Abdominal pain—Ifosfamide—testicular cancer	0.000785	0.00131	CcSEcCtD
Ceftriaxone—Body temperature increased—Ifosfamide—testicular cancer	0.000785	0.00131	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Etoposide—testicular cancer	0.000784	0.00131	CcSEcCtD
Ceftriaxone—Infection—Etoposide—testicular cancer	0.000779	0.0013	CcSEcCtD
Ceftriaxone—Ataxia—Doxorubicin—testicular cancer	0.000778	0.0013	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Doxorubicin—testicular cancer	0.000775	0.0013	CcSEcCtD
Ceftriaxone—Neutropenia—Methotrexate—testicular cancer	0.000773	0.00129	CcSEcCtD
Ceftriaxone—Paraesthesia—Cisplatin—testicular cancer	0.000769	0.00129	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Etoposide—testicular cancer	0.000768	0.00128	CcSEcCtD
Ceftriaxone—Eosinophilia—Epirubicin—testicular cancer	0.000766	0.00128	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Etoposide—testicular cancer	0.000758	0.00127	CcSEcCtD
Ceftriaxone—Pancreatitis—Epirubicin—testicular cancer	0.000758	0.00127	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Doxorubicin—testicular cancer	0.000756	0.00126	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000745	0.00125	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000745	0.00125	CcSEcCtD
Ceftriaxone—Diarrhoea—Dactinomycin—testicular cancer	0.000741	0.00124	CcSEcCtD
Ceftriaxone—Vomiting—Bleomycin—testicular cancer	0.000739	0.00124	CcSEcCtD
Ceftriaxone—Rash—Bleomycin—testicular cancer	0.000733	0.00123	CcSEcCtD
Ceftriaxone—Pain—Cisplatin—testicular cancer	0.000732	0.00122	CcSEcCtD
Ceftriaxone—Dermatitis—Bleomycin—testicular cancer	0.000732	0.00122	CcSEcCtD
Ceftriaxone—Hypersensitivity—Ifosfamide—testicular cancer	0.000732	0.00122	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00073	0.00122	CcSEcCtD
Ceftriaxone—Renal failure—Methotrexate—testicular cancer	0.000724	0.00121	CcSEcCtD
Ceftriaxone—Neutropenia—Epirubicin—testicular cancer	0.000723	0.00121	CcSEcCtD
Ceftriaxone—Stomatitis—Methotrexate—testicular cancer	0.000718	0.0012	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—testicular cancer	0.000708	0.00118	CcSEcCtD
Ceftriaxone—Feeling abnormal—Cisplatin—testicular cancer	0.000706	0.00118	CcSEcCtD
Ceftriaxone—Paraesthesia—Etoposide—testicular cancer	0.000704	0.00118	CcSEcCtD
Ceftriaxone—Pruritus—Ifosfamide—testicular cancer	0.000703	0.00118	CcSEcCtD
Ceftriaxone—Haematuria—Methotrexate—testicular cancer	0.000702	0.00117	CcSEcCtD
Ceftriaxone—Pancreatitis—Doxorubicin—testicular cancer	0.000701	0.00117	CcSEcCtD
Ceftriaxone—Epistaxis—Methotrexate—testicular cancer	0.000695	0.00116	CcSEcCtD
Ceftriaxone—Nausea—Bleomycin—testicular cancer	0.00069	0.00115	CcSEcCtD
Ceftriaxone—Vomiting—Dactinomycin—testicular cancer	0.000689	0.00115	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—testicular cancer	0.000687	0.00115	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000683	0.00114	CcSEcCtD
Ceftriaxone—Rash—Dactinomycin—testicular cancer	0.000683	0.00114	CcSEcCtD
Ceftriaxone—Diarrhoea—Ifosfamide—testicular cancer	0.000679	0.00114	CcSEcCtD
Ceftriaxone—Renal failure—Epirubicin—testicular cancer	0.000678	0.00113	CcSEcCtD
Ceftriaxone—Body temperature increased—Cisplatin—testicular cancer	0.000677	0.00113	CcSEcCtD
Ceftriaxone—Jaundice—Epirubicin—testicular cancer	0.000672	0.00112	CcSEcCtD
Ceftriaxone—Stomatitis—Epirubicin—testicular cancer	0.000672	0.00112	CcSEcCtD
Ceftriaxone—Pain—Etoposide—testicular cancer	0.000671	0.00112	CcSEcCtD
Ceftriaxone—Neutropenia—Doxorubicin—testicular cancer	0.000669	0.00112	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—testicular cancer	0.000665	0.00111	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—testicular cancer	0.000661	0.00111	CcSEcCtD
Ceftriaxone—Haematuria—Epirubicin—testicular cancer	0.000657	0.0011	CcSEcCtD
Ceftriaxone—Dizziness—Ifosfamide—testicular cancer	0.000657	0.0011	CcSEcCtD
Ceftriaxone—Epistaxis—Epirubicin—testicular cancer	0.00065	0.00109	CcSEcCtD
Ceftriaxone—Feeling abnormal—Etoposide—testicular cancer	0.000646	0.00108	CcSEcCtD
Ceftriaxone—Nausea—Dactinomycin—testicular cancer	0.000644	0.00108	CcSEcCtD
Ceftriaxone—Agranulocytosis—Epirubicin—testicular cancer	0.000643	0.00108	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Etoposide—testicular cancer	0.000641	0.00107	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000632	0.00106	CcSEcCtD
Ceftriaxone—Vomiting—Ifosfamide—testicular cancer	0.000631	0.00106	CcSEcCtD
Ceftriaxone—Hypersensitivity—Cisplatin—testicular cancer	0.000631	0.00106	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—testicular cancer	0.000627	0.00105	CcSEcCtD
Ceftriaxone—Rash—Ifosfamide—testicular cancer	0.000626	0.00105	CcSEcCtD
Ceftriaxone—Dermatitis—Ifosfamide—testicular cancer	0.000626	0.00105	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—testicular cancer	0.000625	0.00105	CcSEcCtD
Ceftriaxone—Urticaria—Etoposide—testicular cancer	0.000623	0.00104	CcSEcCtD
Ceftriaxone—Haemoglobin—Epirubicin—testicular cancer	0.000622	0.00104	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—testicular cancer	0.000622	0.00104	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—testicular cancer	0.000622	0.00104	CcSEcCtD
Ceftriaxone—Abdominal pain—Etoposide—testicular cancer	0.00062	0.00104	CcSEcCtD
Ceftriaxone—Body temperature increased—Etoposide—testicular cancer	0.00062	0.00104	CcSEcCtD
Ceftriaxone—Haemorrhage—Epirubicin—testicular cancer	0.000619	0.00104	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—testicular cancer	0.000608	0.00102	CcSEcCtD
Ceftriaxone—Epistaxis—Doxorubicin—testicular cancer	0.000602	0.00101	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—testicular cancer	0.000595	0.000996	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—testicular cancer	0.000593	0.000992	CcSEcCtD
Ceftriaxone—Nausea—Ifosfamide—testicular cancer	0.00059	0.000987	CcSEcCtD
Ceftriaxone—Diarrhoea—Cisplatin—testicular cancer	0.000586	0.00098	CcSEcCtD
Ceftriaxone—Erythema multiforme—Epirubicin—testicular cancer	0.000585	0.000979	CcSEcCtD
Ceftriaxone—Hypersensitivity—Etoposide—testicular cancer	0.000578	0.000967	CcSEcCtD
Ceftriaxone—Haemoglobin—Doxorubicin—testicular cancer	0.000576	0.000963	CcSEcCtD
Ceftriaxone—Flushing—Epirubicin—testicular cancer	0.000574	0.000961	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—testicular cancer	0.000573	0.000958	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—testicular cancer	0.000564	0.000943	CcSEcCtD
Ceftriaxone—Chills—Epirubicin—testicular cancer	0.000555	0.000929	CcSEcCtD
Ceftriaxone—Pruritus—Etoposide—testicular cancer	0.000555	0.000928	CcSEcCtD
Ceftriaxone—Vomiting—Cisplatin—testicular cancer	0.000544	0.00091	CcSEcCtD
Ceftriaxone—Erythema multiforme—Doxorubicin—testicular cancer	0.000541	0.000906	CcSEcCtD
Ceftriaxone—Rash—Cisplatin—testicular cancer	0.00054	0.000903	CcSEcCtD
Ceftriaxone—Dermatitis—Cisplatin—testicular cancer	0.000539	0.000902	CcSEcCtD
Ceftriaxone—Diarrhoea—Etoposide—testicular cancer	0.000537	0.000898	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—testicular cancer	0.000534	0.000893	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—testicular cancer	0.000532	0.00089	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—testicular cancer	0.000531	0.000889	CcSEcCtD
Ceftriaxone—Flatulence—Epirubicin—testicular cancer	0.000531	0.000888	CcSEcCtD
Ceftriaxone—Dysgeusia—Epirubicin—testicular cancer	0.000528	0.000882	CcSEcCtD
Ceftriaxone—Malaise—Methotrexate—testicular cancer	0.000519	0.000868	CcSEcCtD
Ceftriaxone—Dizziness—Etoposide—testicular cancer	0.000519	0.000868	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—testicular cancer	0.000515	0.000862	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—testicular cancer	0.000514	0.000859	CcSEcCtD
Ceftriaxone—Nausea—Cisplatin—testicular cancer	0.000509	0.000851	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Epirubicin—testicular cancer	0.0005	0.000836	CcSEcCtD
Ceftriaxone—Convulsion—Methotrexate—testicular cancer	0.000499	0.000834	CcSEcCtD
Ceftriaxone—Vomiting—Etoposide—testicular cancer	0.000499	0.000834	CcSEcCtD
Ceftriaxone—Anaemia—Epirubicin—testicular cancer	0.000498	0.000833	CcSEcCtD
Ceftriaxone—Agitation—Epirubicin—testicular cancer	0.000495	0.000828	CcSEcCtD
Ceftriaxone—Rash—Etoposide—testicular cancer	0.000495	0.000827	CcSEcCtD
Ceftriaxone—Dermatitis—Etoposide—testicular cancer	0.000494	0.000826	CcSEcCtD
Ceftriaxone—Headache—Etoposide—testicular cancer	0.000491	0.000822	CcSEcCtD
Ceftriaxone—Flatulence—Doxorubicin—testicular cancer	0.000491	0.000822	CcSEcCtD
Ceftriaxone—Dysgeusia—Doxorubicin—testicular cancer	0.000488	0.000816	CcSEcCtD
Ceftriaxone—Malaise—Epirubicin—testicular cancer	0.000486	0.000813	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—testicular cancer	0.000484	0.00081	CcSEcCtD
Ceftriaxone—Leukopenia—Epirubicin—testicular cancer	0.000482	0.000807	CcSEcCtD
Ceftriaxone—Palpitations—Epirubicin—testicular cancer	0.000476	0.000796	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—testicular cancer	0.00047	0.000786	CcSEcCtD
Ceftriaxone—Convulsion—Epirubicin—testicular cancer	0.000467	0.000781	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—testicular cancer	0.000467	0.000781	CcSEcCtD
Ceftriaxone—Nausea—Etoposide—testicular cancer	0.000466	0.000779	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000462	0.000774	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—testicular cancer	0.000461	0.000771	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—testicular cancer	0.00046	0.000769	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—testicular cancer	0.000458	0.000766	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methotrexate—testicular cancer	0.000454	0.00076	CcSEcCtD
Ceftriaxone—Discomfort—Epirubicin—testicular cancer	0.000453	0.000758	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—testicular cancer	0.00045	0.000752	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—testicular cancer	0.000446	0.000746	CcSEcCtD
Ceftriaxone—Palpitations—Doxorubicin—testicular cancer	0.00044	0.000737	CcSEcCtD
Ceftriaxone—Oedema—Epirubicin—testicular cancer	0.00044	0.000735	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Epirubicin—testicular cancer	0.00044	0.000735	CcSEcCtD
Ceftriaxone—Infection—Epirubicin—testicular cancer	0.000437	0.000731	CcSEcCtD
Ceftriaxone—Convulsion—Doxorubicin—testicular cancer	0.000432	0.000722	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Epirubicin—testicular cancer	0.00043	0.00072	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Epirubicin—testicular cancer	0.000425	0.000711	CcSEcCtD
Ceftriaxone—Paraesthesia—Methotrexate—testicular cancer	0.000422	0.000706	CcSEcCtD
Ceftriaxone—Discomfort—Doxorubicin—testicular cancer	0.000419	0.000701	CcSEcCtD
Ceftriaxone—Dyspepsia—Methotrexate—testicular cancer	0.000414	0.000692	CcSEcCtD
Ceftriaxone—Oedema—Doxorubicin—testicular cancer	0.000407	0.00068	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Doxorubicin—testicular cancer	0.000407	0.00068	CcSEcCtD
Ceftriaxone—Infection—Doxorubicin—testicular cancer	0.000404	0.000676	CcSEcCtD
Ceftriaxone—Pain—Methotrexate—testicular cancer	0.000402	0.000672	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Doxorubicin—testicular cancer	0.000398	0.000666	CcSEcCtD
Ceftriaxone—Paraesthesia—Epirubicin—testicular cancer	0.000395	0.00066	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000393	0.000658	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—testicular cancer	0.000387	0.000648	CcSEcCtD
Ceftriaxone—Dyspepsia—Epirubicin—testicular cancer	0.000387	0.000647	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000384	0.000643	CcSEcCtD
Ceftriaxone—Pain—Epirubicin—testicular cancer	0.000376	0.000629	CcSEcCtD
Ceftriaxone—Urticaria—Methotrexate—testicular cancer	0.000373	0.000624	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—testicular cancer	0.000371	0.000621	CcSEcCtD
Ceftriaxone—Body temperature increased—Methotrexate—testicular cancer	0.000371	0.000621	CcSEcCtD
Ceftriaxone—Paraesthesia—Doxorubicin—testicular cancer	0.000365	0.000611	CcSEcCtD
Ceftriaxone—Feeling abnormal—Epirubicin—testicular cancer	0.000362	0.000606	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Epirubicin—testicular cancer	0.00036	0.000601	CcSEcCtD
Ceftriaxone—Dyspepsia—Doxorubicin—testicular cancer	0.000358	0.000599	CcSEcCtD
Ceftriaxone—Urticaria—Epirubicin—testicular cancer	0.000349	0.000584	CcSEcCtD
Ceftriaxone—Pain—Doxorubicin—testicular cancer	0.000348	0.000582	CcSEcCtD
Ceftriaxone—Body temperature increased—Epirubicin—testicular cancer	0.000348	0.000581	CcSEcCtD
Ceftriaxone—Abdominal pain—Epirubicin—testicular cancer	0.000348	0.000581	CcSEcCtD
Ceftriaxone—Hypersensitivity—Methotrexate—testicular cancer	0.000346	0.000579	CcSEcCtD
Ceftriaxone—Feeling abnormal—Doxorubicin—testicular cancer	0.000335	0.000561	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000333	0.000556	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—testicular cancer	0.000332	0.000556	CcSEcCtD
Ceftriaxone—Hypersensitivity—Epirubicin—testicular cancer	0.000324	0.000542	CcSEcCtD
Ceftriaxone—Urticaria—Doxorubicin—testicular cancer	0.000323	0.000541	CcSEcCtD
Ceftriaxone—Abdominal pain—Doxorubicin—testicular cancer	0.000322	0.000538	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—testicular cancer	0.000322	0.000538	CcSEcCtD
Ceftriaxone—Diarrhoea—Methotrexate—testicular cancer	0.000321	0.000538	CcSEcCtD
Ceftriaxone—Pruritus—Epirubicin—testicular cancer	0.000311	0.00052	CcSEcCtD
Ceftriaxone—Dizziness—Methotrexate—testicular cancer	0.000311	0.00052	CcSEcCtD
Ceftriaxone—Diarrhoea—Epirubicin—testicular cancer	0.000301	0.000503	CcSEcCtD
Ceftriaxone—Hypersensitivity—Doxorubicin—testicular cancer	0.0003	0.000501	CcSEcCtD
Ceftriaxone—Vomiting—Methotrexate—testicular cancer	0.000299	0.0005	CcSEcCtD
Ceftriaxone—Rash—Methotrexate—testicular cancer	0.000296	0.000495	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—testicular cancer	0.000296	0.000495	CcSEcCtD
Ceftriaxone—Headache—Methotrexate—testicular cancer	0.000294	0.000492	CcSEcCtD
Ceftriaxone—Dizziness—Epirubicin—testicular cancer	0.000291	0.000486	CcSEcCtD
Ceftriaxone—Pruritus—Doxorubicin—testicular cancer	0.000288	0.000481	CcSEcCtD
Ceftriaxone—Vomiting—Epirubicin—testicular cancer	0.00028	0.000468	CcSEcCtD
Ceftriaxone—Nausea—Methotrexate—testicular cancer	0.000279	0.000467	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—testicular cancer	0.000278	0.000466	CcSEcCtD
Ceftriaxone—Rash—Epirubicin—testicular cancer	0.000277	0.000464	CcSEcCtD
Ceftriaxone—Dermatitis—Epirubicin—testicular cancer	0.000277	0.000463	CcSEcCtD
Ceftriaxone—Headache—Epirubicin—testicular cancer	0.000275	0.000461	CcSEcCtD
Ceftriaxone—Dizziness—Doxorubicin—testicular cancer	0.000269	0.00045	CcSEcCtD
Ceftriaxone—Nausea—Epirubicin—testicular cancer	0.000261	0.000437	CcSEcCtD
Ceftriaxone—Vomiting—Doxorubicin—testicular cancer	0.000259	0.000433	CcSEcCtD
Ceftriaxone—Rash—Doxorubicin—testicular cancer	0.000257	0.000429	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—testicular cancer	0.000256	0.000429	CcSEcCtD
Ceftriaxone—Headache—Doxorubicin—testicular cancer	0.000255	0.000426	CcSEcCtD
Ceftriaxone—Nausea—Doxorubicin—testicular cancer	0.000242	0.000404	CcSEcCtD
